Tradestie Institutional Equity Comparison Engine
NBP vs NGNE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NBP Overall Edge
NBP Captures Institutional Edge (2โ2 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NBP (NBP) driven by superior Valuation, Options & Structure while NGNE counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, NBP trades at 2.7x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NGNE at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NBP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NGNE sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NBP
NBP 2.7x vs NGNE N/M Fwd P/E
Growth & Margin Winner
NGNE
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
NGNE
1Y -81.0% vs -11.6% ยท 52W Pos 0% vs 27%
Options & Structure Winner
NBP
UNCLASSIFIED (N/A IV) vs BREAKDOWN (9th %ile IV)
NBP
US Equity
NBP
Institutional Equity
$0.79
-6.66% 1D
Market Cap
$96.3M
1M Return
-37.04%
1Y Return
-80.98%
Forward P/E
2.7x
Unified AI Score
51.9 / 100
HOLD
Tech 60.0
Fund 50.0
Flow 50.0
Mom 55.0
NGNE
NASDAQ
Neurogene, Inc. Common Stock
Pharmaceutical Preparations
$23.42
-2.13% 1D
Market Cap
$494.8M
1M Return
+0.73%
1Y Return
-11.59%
Forward P/E
N/M
Unified AI Score
38.8 / 100
SELL
Tech 20.0
Fund 44.0
Flow 68.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NBP -80.98%
NGNE -11.59%
Spread: +69.39 pp (NGNE Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NBP TTM Op. Margin: 0.0%
NGNE TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NBP vs NGNE. Trailing 12-month operating profitability (NBP 0.0% vs NGNE 0.0%) and valuation multiples (NBP 2.7x vs NGNE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NBP | NGNE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $96.3M | $494.8M | Larger Scale | NGNE |
| Trailing P/E Ratio Valuation | 2.7x | N/M | Lower Multiple | NBP |
| Forward P/E Ratio Valuation | 2.7x | N/M | Lower Multiple | NBP |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -59.1% | -38.4% | Higher ROE | NGNE |
| 52-Week Range Position Momentum | 0% ($1โ$5) | 27% ($16โ$44) | Stronger Trend | NGNE |
| Beta / 30D Volatility Risk Regime | 1.66ฮฒ ยท 81% Vol | 1.55ฮฒ ยท 89% Vol | Lower Realized Risk | NBP |
| Unified Institutional Score Composite Signal | 51.9 / 100 (HOLD) | 38.8 / 100 (SELL) | Higher Composite | NBP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NBP vs NGNE Buy Guide
NBP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NGNE
BREAKDOWN
91d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NBP nor NGNE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.